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Abstract
Background: In Kenya, detailed data on the age-specific burden of influenza and RSV are essential to inform use of limited
vaccination and treatment resources.
Methods: We analyzed surveillance data from August 2009 to July 2012 for hospitalized severe acute respiratory illness
(SARI) and outpatient influenza-like illness (ILI) at two health facilities in western Kenya to estimate the burden of influenza
and respiratory syncytial virus (RSV). Incidence rates were estimated by dividing the number of cases with laboratory-
confirmed virus infections by the mid-year population. Rates were adjusted for healthcare-seeking behavior, and to account
for patients who met the SARI/ILI case definitions but were not tested.
Results: The average annual incidence of influenza-associated SARI hospitalization per 1,000 persons was 2.7 (95% CI 1.8–
3.9) among children ,5 years and 0.3 (95% CI 0.2–0.4) among persons $5 years; for RSV-associated SARI hospitalization, it
was 5.2 (95% CI 4.0–6.8) among children ,5 years and 0.1 (95% CI 0.0–0.2) among persons $5 years. The incidence of
influenza-associated medically-attended ILI per 1,000 was 24.0 (95% CI 16.6–34.7) among children ,5 years and 3.8 (95% CI
2.6–5.7) among persons $5 years. The incidence of RSV-associated medically-attended ILI was 24.6 (95% CI 17.0–35.4)
among children ,5 years and 0.8 (95% CI 0.3–1.9) among persons $5 years.
Conclusions: Influenza and RSV both exact an important burden in children. This highlights the possible value of influenza
vaccines, and future RSV vaccines, for Kenyan children.
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Introduction
Acute lower respiratory tract infections account for an estimated
1.9 million deaths in children ,5 years of age annually, up to
90% of which occur in the developing world [1–3]. In Africa and
Asia, acute lower respiratory tract infections are two to ten times
more common than in the USA [4], and have three to seven-fold
worse outcomes than in the industrialized world [5]. A large
fraction of human respiratory tract infections are associated with
viruses including influenza A and B, and respiratory syncytial virus
(RSV) [6]. Safe and effective vaccines for influenza are available
[7,8], but very limited quantities of influenza vaccine are currently
being used in Kenya, and elsewhere in Africa [9]. Efforts are on-
going to develop a vaccine for RSV [10]. However additional and
more detailed data on burden of disease may be required before
these vaccines are used more widely.
While some data suggest a significant burden of hospitalized
influenza in Kenya, many of the data come from persons seeking
medical care during the period of the 2009 influenza
A(H1N1)pdm09 pandemic with few data from either the pre-
or post-pandemic periods [11–13]. The age-specific burden of
influenza has also not clearly been defined among infants ,
6 months, or among those aged 6–12 months. Such data could
be used to inform whether vaccination of pregnant women to
protect infants ,6 months of age (for whom no influenza vaccine
is currently licensed) through maternal antibody transfer and/or
vaccination of children older than six months of age may be
viable vaccination strategies for Kenya. Data on the burden of
RSV have also been limited to those seeking medical care –
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focused on children ,5 years – at the Coastal and Western areas
of Kenya [14–17].
To address these gaps we estimated the age-specific burden and
seasonality of medically-attended, and non-medically attended
influenza and RSV in western Kenya during the period 2009–
2012.
Methods
Since August 2009 the Kenya Medical Research Institute and
the Centers for Disease Control and Prevention (KEMRI/CDC)
have conducted hospital-based surveillance for severe acute
respiratory illness (SARI) at Siaya District Hospital (SDH) and
outpatient surveillance for influenza-like illness (ILI) at Ting’-
wang’i Health Centre (THC) in western Kenya. Both facilities are
located in Karemo Division, where KEMRI/CDC implements a
Health Demographic Surveillance System (HDSS), with an
approximate population of 80,000 [18]. Karemo’s population is
culturally homogenous, and almost entirely rural [19]. The area is
endemic for malaria with a high child mortality rate (212 deaths
per 1000 live births in 2008) [19] and a high HIV prevalence,
which in 2008 was estimated at 14% among persons aged $18
years [20].
Data collection and case definitions
From August 2009 to July 2012, trained nurses and clinical
officers enrolled all consenting patients who were admitted to
SDH with SARI or sought outpatient healthcare at THC for ILI.
ILI was defined as axillary temperature $38uC and cough or sore
throat with an onset with the past 14 days in an outpatient for
persons of all ages. SARI was defined as hospitalization with cough
or difficulty breathing or pleural chest pain with an onset within
the last 14 days. Hospitalized SARI patients were followed up for
the duration of their hospitalization until they were discharged,
transferred or died. We also estimated rates of non-medically
attended ILI and SARI using the proportion of persons that
sought care for acute respiratory infections (ARI), and pneumonia,
respectively, from a health utilization survey implemented in
Western Kenya in 2005 [21]. In this survey, ARI was defined
more narrowly than ILI as cough and difficulty in breathing within
the last 14 days [21]. Pneumonia was defined as ARI lasting for
more than two days (excluding the past 14 days) within the
preceding 12 months or a diagnosis of ’pneumonia’ by a
healthcare worker. Data processing and management procedures
have been described previously [13].
Specimen collection and laboratory methods
Patients meeting SARI and ILI case definitions were enrolled in
medical facility-based surveillance and nasopharyngeal (NP) and
oropharyngeal (OP) swabs were collected, combined into a single
viral transport media, and tested by real-time reverse transcription
polymerase chain reaction (rRT-PCR) for influenza A and B
viruses and RSV [12,13].
Patients admitted to the hospital for any reason were offered
voluntary counseling and testing for HIV. Details of HIV testing at
SDH have also been described previously [22].
Data analysis
Descriptive analyses. We used univariate analysis methods
including mean, median and proportions to describe demographic
characteristics and laboratory outcomes of patients. Chi-square
tests were used to assess associations for categorical variables.
Mann-Whitney rank sum tests were used to test for differences in
the age distribution between patients who were tested and those
who were not tested for influenza viruses and RSV.
Estimating the incidence rates of hospitalized SARI, and
influenza and RSV-associated SARI. As SDH is the only
hospital located within Karemo Division, age-specific incidence
rates (for 11 age groups: ,6 months, 6–11 months, 12–
23 months, 2–4 years, 5–17 years, 18–34 years, 35–49 years, $
50 years, ,5 years, $5 years, all ages) of hospitalized SARI were
estimated by dividing the number of cases enrolled in the HDSS
for each age group, by the mid-year population in each age group
residing in Karemo Division who were enrolled in HDSS.
Similarly, the age-specific incidence rates of Influenza and RSV-
associated SARI hospitalizations were calculated by dividing the
number laboratory-confirmed influenza or RSV cases enrolled in
the HDSS for each age group, by the mid-year population in each
age group. Rates of influenza and RSV-associated SARI were
adjusted for patients who met the SARI case definition but from
whom NP/OP swabs were not collected and tested (for each age
group, the adjusted number of cases was equal to the number of
laboratory-confirmed cases divided by the proportion of patients
with SARI who were tested). We compared incidence rates of
influenza and RSV for residents living within 0–5 kilometers
(KM), 0–10 KM, and 0–20 KM of the hospital. We did this in
order to assess whether rates of hospitalized influenza and RSV
declined with inclusion of persons who lived within Karemo
Division but farther from the hospital (Figure 1).
Estimating the incidence rates of outpatient ILI, and
Influenza and RSV-associated ILI. We estimated age-specific
incidence of outpatient influenza and RSV virus infections for the
11 aforementioned age groups. To do this we examined the
outpatient registers for children ,5 years and persons $5 years at
all seven outpatient facilities in Karemo Division to obtain the area
of residence (village and sub-location) for each outpatient visit for a
two-year period. From each outpatient facility we calculated the
number and proportion of patients seen who were residents of
Karemo Division by month and age (,5 years and $5 years). We
summed the number of patients seen at the seven facilities who
were residents of Karemo and calculated the proportion of those
who visited THC. We determined that approximately 10%
(12,464/128,967) of outpatient visits among Karemo residents
between 2010 and 2011 occurred at THC (11% and 9% for
children ,5 years and persons $5 years, respectively). The crude
incidence rates (outpatient medically-attended ILI; influenza-
associated ILI; and RSV-associated ILI) were calculated by
dividing the number of cases by the mid-year population in each
age group residing in the Karemo Division who were enrolled in
HDSS. After calculating crude rates by age group, we calculated
adjusted rates by dividing the crude rates by the proportions of
patients who visited THC in each age group (0.11 for children ,
5 years and 0.09 for persons $5 years). Influenza and RSV-
associated incidence rates were then further adjusted for ILI
patients who did not have NP/OP swabs collected (for each age
group, the adjusted number of cases was equal to the number of
laboratory-confirmed cases divided by the proportion of patients
with ILI who were tested) (Figure 1).
Estimating non-medically attended incidence rates of
influenza and RSV. We calculated the total (hospitalized and
non-hospitalized) incidence of influenza and RSV-associated
SARI by dividing the hospitalized SARI-associated incidence
rates by the proportion of reported cases of pneumonia who went
to hospital based on data from a 2005 Health Utilization Survey.
In this survey, health utilization was reported for two age groups –
children ,5 years and persons $5 years. Forty eight percent
(95% CI 35–62) of the children aged ,5 years and 34% (95% CI
Burden of Influenza and RSV in Western Kenya
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23–48) of persons aged $5 years were reported to have sought
care for pneumonia at a hospital. As there was no health
utilization reported for the finer age categories among children ,
5 years and persons $5 years, we used the same adjustment factor
reported in the survey for children ,5 years (48%) for all the age
categories under five years (,6 months, 6–11 months, 12–
23 months, 2–4 years, and ,5 years). Similarly, we used the
same health utilization adjustment factor (34%) reported for
persons $5 years for all the age groups among persons aged
five years or older (5–18 years, $18 years, and $5 years). The
incidence of non-hospitalized SARI associated with influenza and
RSV was then calculated by subtracting the hospitalized influenza
and RSV-associated SARI incidence from the total incidence of
influenza and RSV-associated SARI calculated using health
utilization survey data for each age group (Figure 1).
We took a similar approach to estimate non-medically
attended ILI associated with influenza and RSV. In this survey,
42% (95% CI 33–51) of the children aged ,5 years and 44%
(95% CI 40–53) of persons aged $5 years reported to have
sought care for ARI at a health facility. We used an adjustment
factor of 42% for all the age groups under the age of five years
and 44% for the age groups among patients aged five years or
older. Total age-specific incidence rates of influenza and RSV-
associated ILI were calculated by dividing the medically-
attended ILI incidence rates by the proportion of reported
cases of ARI in the health utilization survey who went to any
facility. The age-specific incidence of non-medically attended
ILI associated with influenza and RSV was calculated by
subtracting the adjusted incidence of medically-attended influ-
enza and RSV estimated from ILI surveillance at THC from
the total incidence of influenza and RSV-associated ILI
calculated using health utilization survey data, for each age
group (Figure 1). Incidence rates were reported per 1000
persons, and the Poisson approximation method was used to
calculate the 95% confidence intervals (CIs) around point
estimates [23], separately for each age group. Data analysis was
performed using Stata version 12.1 (Stata Corp, College Station,
Texas).
Ethical review
This study was approved by both the Ethical Review
Committee of the Kenya Medical Research Institute (KEMRI
SSC-1801) and Institutional Review Board of CDC-Atlanta (CDC
IRB #3308). Written informed consent was obtained from all
participants or caretakers/guardians of all minors prior to
enrolment in the study and sample collection.
Results
Descriptive analyses
We enrolled 5507 patients hospitalized with SARI at SDH,
and 1632 patients with ILI at THC. Most (SARI= 75%,
ILI = 77%) were children ,5 years old. Although the study case
definition was different from the current WHO case definition
Figure 1. Flow diagram of the steps used for the calculation of incidence rates.
doi:10.1371/journal.pone.0105543.g001
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for SARI, seventy percent of the SARI cases included in this
study also met the new WHO case definition [75% among
children ,5 years (70% in children ,6 months); and 53% in
persons $5 years] [24]. The median age was 1.6 years and
2.4 years for SARI and ILI patients, respectively, and 50% of
the SARI patients and 53% of the ILI patients were female. Of
the enrolled patients, 4387 (80%) of those with SARI and 1508
(92%) of those with ILI were tested for influenza and RSV
(Table 1). When we compared SARI patients who were tested
with those who were not, those tested were more likely to be
male (50% vs. 46%; p,0.05), and the median age among those
tested was 1.6 years compared to 1.5 years among those not
tested (p,0.001). Similarly, ILI patients who were tested for
influenza viruses or RSV were significantly older than those not
tested (median age 2.4 years vs. 1.8 years; p,0.001). Case-
fatality was significantly higher in SARI patients who were not
tested for influenza or RSV than in those who were tested (18%
vs. 4%; p,0.001).
Influenza viruses were detected in 348/4387 (8%) of the SARI
patients (Table 1); 253 (6%) were positive for influenza A, 97
(2%) were positive for influenza B and 2 (0.1%) were positive for
positive for both influenza A and B. The most commonly
detected subtypes during the study period were influenza
A(H1N1)pdm09 and influenza A(H3N2). RSV was detected in
437 (10%) of the SARI patients who were tested (12% in
children ,5 years; 4% in persons $5 years old). HIV-infected
Table 1. Characteristics of patients who were admitted at SDH with SARI and those who presented to THC with ILI and were
tested for respiratory pathogens, August 2009– July 2012.
In-patients (SARI patients) Out-patients (ILI patients)
Total Number
(N=5,507)
Enrolled in
Karemo HDSS
(N=2,136)
Total Number
(N=1,632)
Enrolled in Karemo
HDSS (N=1,186)
n (%) n (%) n (%) n (%)
Sex
Male 2,800(50.8) 1,097(51.4) 779(47.7) 567(47.8)
Female 2,707(49.2) 1,039(48.6) 853(52.3) 619(52.2)
Age Group
,6 months 918(16.7) 351(16.4) 134(8.2) 85(7.2)
6–11 months 1,040(18.9) 414(19.4) 207(12.7) 140(11.8)
12–23 months 1,134(20.6) 495(23.2) 339(20.8) 248(20.9)
2–4 years 1,018(18.5) 411(19.2) 570(34.9) 431(36.3)
5–17 years 417(7.6) 174(8.2) 311(19.1) 236(19.9)
18–34 years 493(9.0) 133(6.2) 53(3.3) 35(3.0)
35–49 years 223(4.1) 74(3.5) 11(0.7) 7(0.6)
$50 years 264(4.8) 84(3.9) 7(0.4) 4(0.3)
Median age years (Range) 1.6(0.01–90.0) 1.6(0.01–90.0) 2.4(0.1–0 63.4) 2.4(0.02–63.4)
Died in the hospital 390(7.1) 103(4.8) - -
HIV status
Negative 2,917(53.0) 1,190(55.7) 482(29.5) 337(28.4)
Positive¥ 654(11.9) 230(10.8) 28(1.7) 12(1.0)
Unknown 1,936(35.2) 716(33.5) 1,122(68.8) 837(70.6)
Sampled and tested for influenza and RSV 4,387(79.7) 1730(81.0) 1,508(92.4) 1,092(92.1)
Respiratory pathogen isolated
Influenza A or B* 348(7.9) 124(7.2) 206(13.7) 155(14.2)
Influenza A* 253(5.8) 93(5.4) 159(10.5) 119(10.9)
Seasonal A (H1N1)** 2(0.8) 0(0.0) 1(0.6) 1(0.8)
Seasonal A (H3N2)** 63(24.9) 16(17.2) 52(32.7) 42(35.3)
Pandemic H1N1** 93(36.8) 39(41.9) 82(51.6) 59(49.6)
Unsubtypable** 10(4.0) 3(3.2) 3(1.9) 3(2.5)
Not subtyped** 81(32.0) 32(34.4) 18(11.3) 14(11.8)
Influenza B* 97(2.2) 32(1.9) 51(3.4) 38(3.5)
Influenza A and B* 2(0.1) 1(0.1) 4(0.3) 2(0.2)
Respiratory syncytial virus (RSV)* 437(10.0) 176(10.2) 138(9.7) 101(9.7)
Influenza-RSV co-infection* 18(0.4) 7(0.4) 14(0.9) 11(1.0)
¥18% of those with known HIV status were HIV infected; *Denominator is the number of those who tested for Influenza and RSV; **Denominator in the number of
influenza A cases.
doi:10.1371/journal.pone.0105543.t001
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patients were as likely as non-HIV infected patients to test
positive for these viral pathogens when we adjusted for age
(p = 0.284 for influenza; and p= 0.957 for RSV). The case-
fatality proportion was similar for SARI patients who tested
positive compared to those who tested negative for influenza
[13/348 (4%) vs. 171/4039 (4%); p = 0.66] and RSV [14/437
(3%) vs. 170/3950 (4%); p = 0.28], respectively. The median age
among the SARI patients was significantly higher in influenza
positive patients compared to RSV positive patients [3.0 vs.
1.1 years; p,0.001].
Of the 1508 ILI patients tested, 206 (14%) tested positive for
influenza viruses; [159 (11%) were positive for influenza A; 51
(3%) for influenza B; and 4 (0.3%) were positive for both influenza
A and B]. The most commonly detected subtypes during the three
years were influenza A(H1N1)pdm09 and influenza A(H3N2).
RSV was detected in 138 out of 1,508 patients (10%) [11% in
children ,5 years; 6% in persons $5 years old] (Table 1).
Figure 2. Seasonality of Influenza and RSV in Western Kenya, Aug 2009– Jul 2012.
doi:10.1371/journal.pone.0105543.g002
Figure 3. Seasonality of influenza and circulating subtypes in Western Kenya, Aug 2009– Jul 2012.
doi:10.1371/journal.pone.0105543.g003
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Similarly, the median age among ILI patients was significantly
higher in the influenza positive patients compared to RSV positive
patients [4.4 vs. 2.4; p,0.001].
Influenza-virus-positive cases were detected throughout the
study period with the influenza-positive proportions observed to be
lower in the hotter months between December and January every
year. RSV peaked more predictably during May-July of each year
(Figure 2). Influenza A(H1N1)pdm09 was the dominant influenza
virus in circulation during late 2009 and early 2010, and again
during late 2010 and early 2011. Influenza A(H3N2) was the
dominant influenza virus in circulation during the periods May
2010 to October 2010 and also from January 2012 to July 2012.
Influenza B viruses were detected mostly between April 2011 and
December 2011 (Figure 3).
Incidence of hospitalized SARI, and influenza and RSV-
associated SARI
The estimated average annual incidence rate of SARI
hospitalizations among children ,5 years of age was 43.6(95%
CI 40.1–47.3) [106.2(95% CI 88.6–127.3) in children ,
6 months; 120.2(95% CI 101.7–142.0) in children 6–11 months;
67.6(95% CI 58.1–78.8) in children 12–23 months; and
16.9(95% CI 14.3–20.0) in children 2–4 years] and 2.4(95%
CI 2.0–2.8) among persons aged $5 years cases per 1000
persons (Table 2). The average annual adjusted incidence of
influenza-associated hospitalized SARI was 0.7 per 1000 persons
(95% CI 0.5–0.9) and was higher among children aged ,
5 years [2.7 (95% CI 1.8–3.9)] compared to persons aged $
5 years [0.3 (95% CI 0.2–0.4)] (Table 3). Influenza-associated
hospitalizations were 5.7(95% CI 2.4–13.8) in children ,
6 months; 4.7(95% CI 1.8–11.9) in children aged 6–11 months;
and 4.4(95% CI 2.3–8.5) in children aged 12–23 months. The
incidence of influenza-associated SARI hospitalizations was not
significantly different among residents of Karemo living within
5 KM of SDH [,5 years = 2.6 (95% CI 1.5–4.7); $
5 years = 0.4(95% CI 0.2–0.7)] compared to residents living
within 10 KM of SDH [,5 years = 2.4 (95% CI 1.6–3.7); $
5 years = 0.3(95% CI 0.2–0.5)] and those living with 20 KM of
SDH [,5 years = 2.7 (95% CI 1.8–3.9); $5 years = 0.3(95% CI
0.2–0.4)] (Figure 4).
Incidence rates of RSV-associated hospitalized SARI were 0.9
(95% CI 0.7–1.2) and were higher in children aged ,5 years
[5.2 (95% CI 4.0–6.8)] than in persons aged $5 years [0.1
(95% CI 0.0–0.2)] (Table 3). RSV-associated hospitalizations
were highest in children ,2 years old [13.4(95% CI 7.5–23.8)
in children ,6 months; 14.0(95% CI 8.1–24.1) in children aged
6–11 months; and 8.1(95% CI 5.0–13.1) in children aged 12–
23 months]. As was the case with influenza, incidence of RSV-
associated SARI was not significantly different in residents of
Karemo living within 5 KM of SDH [,5 years = 4.6(95% CI
3.0–7.2); $5 years = 0.2(95% CI 0.1–0.5)] compared with those
living within 10 KM of SDH [,5 years = 4.9(95% CI 3.7–6.6);
$5 years = 0.1(95% CI 0.0–0.3)] and compared to those with
20 KM of SDH [,5 years = 5.2(95% CI 4.0–6.8); $
5 years = 0.1(95% CI 0.0–0.2)] (Figure 4). More detailed age-
specific incidence rates of hospitalizations associated with
influenza and RSV are presented in Table 3. Incidence rates
of hospitalizations associated with influenza or RSV were higher
in the first year (August 2009– July 2010) compared to the
other two years included in this analysis (Table 4).
Incidence of medically-attended outpatient ILI and
influenza and RSV-associated ILI
The estimated incidence of medically-attended outpatient
visits associated with ILI among children ,5 years of age was
214.9(95% CI 207.1–223.1), and 16.1(95% CI 15.1–17.1)
among persons aged $5 years cases per 1000 persons (Table 2).
The average annual adjusted incidence of medically-attended
ILI associated with influenza was 7.2 (95% CI 5.5–9.4) and was
significantly higher in children aged ,5 years [21.8(95% CI
15.1–31.6)] compared to those aged $5 years [4.3(95% CI2.8–
6.4)]. The average annual incidence of medically-attended ILI
associated with RSV was 4.7 (95% CI 3.3–6.6) and was
significantly higher among children ,5 years [22.3(95%
Table 2. Age-specific average annual rates of SARI hospitalizations and ILI outpatient visits (per 1,000 persons) in Western Kenya,
August 2009– July 2012.
Karemo
Populationa
Proportion of
hospitalizationsb
with SARI n(%)
Average annual SARI
hospitalization
rates (95% CI)
Proportion of
outpatientsc
with ILI n(%)
Average annual
medically-attended
ILI ratesd (95% CI)
Age Group
,6 months 1,102 351/821(42.8) 106.2(88.6–127.3) 85/896(9.5) 233.7(206.9–264.1)
6–11 months 1,148 414/1,050(39.4) 120.2(101.7–142.0) 140/858(16.3) 369.5(336.0–406.4)
12–23 months 2,440 495/1,287(38.5) 67.6(58.1–78.8) 249/1,436(17.3) 309.2(287.9–332.1)
2–4 years 8,097 411/1,267(32.4) 16.9(14.3–20.0) 433/2,435(17.8) 162.1(153.5–171.1)
5–17 years 28,326 174/708(24.6) 2.0(1.6–2.6) 237/2,456(9.6) 31.0(29.0–33.1)
18–34 years 18,270 133/1,452(9.2) 2.4(1.8–3.3) 35/1,152(3.0) 7.1(6.0–8.4)
35–49 years 8,272 74/758(9.8) 3.0(2.0–4.4) 7/461(1.5) 3.1(2.1–4.6)
$50 years 10,397 84/944(8.9) 2.7(1.9–3.9) 4/749(0.5) 1.4(0.9–2.4)
,5 years 12,787 1,671/4,425(37.8) 43.6(40.1–47.3) 907/5,625(16.1) 214.9(207.1–223.1)
$5 years 65,265 465/3,862(12.0) 2.4(2.0–2.8) 283/4,818(5.9) 16.1(15.1–17.1)
All ages 78,052 1,978/8,287(23.9) 8.4(7.8–9.1) 1,179/10,443(11.3) 50.4(48.8–52.0)
aMid–study-period population for Karemo (Aug 2009– Jul 2012); bTotal hospitalizations among residents of Keremo over three years (Aug 2009– Jul 2012); cTotal
outpatient visits to Ting’wang’i by residents of Karemo over three years (Aug 2009– Jul 2012); dAdjusted for outpatient visits to other health facilities in Karemo other
than Ting‘wang’i.
doi:10.1371/journal.pone.0105543.t002
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CI15.5–32.2)] compared to persons aged $5 years [0.9(95% CI
0.4–2.2)] (Table 2). The age-specific incidence rates of outpa-
tient visits associated with influenza and RSV are presented on
Table 3.
Non-medically attended incidence rates of influenza and
RSV SARI and ILI
The incidence of non-hospitalized SARI attributable to
influenza was 1.2 (95% CI 0.9–1.4) [2.9 (95% CI 2.1–4.0) in
persons ,5 years; and 0.5 (95% CI 0.4–0.7) in persons $5 years].
The incidence of non-hospitalized SARI attributable to RSV was
1.6 (95% CI 1.4–2.0) [5.6 (95% CI 4.5–7.1) in persons ,5 years;
and 0.2 (95% CI 0.1–0.3) in persons $5 years] after adjusting for
persons who reported cases of pneumonia but did not go to
hospital.
The overall incidence of non-medically attended ILI attribut-
able to influenza was 9.1 (95% CI 8.5–9.8); 30.1(95% CI27.3–
33.3) in persons ,5 years; and 5.4(95% CI4.9–6.0) in persons $
5 years. The incidence of non-medically attended ILI associated
with RSV was 6.0 (95% CI 5.4–6.5) [30.8(95% CI27.9–34.0) in
persons ,5 years; and 1.1(95% CI0.9–1.4) in persons $5 years]
after adjusting for persons who reported ARI in the 2005 health
utilization survey but did not go to any facility (Table 3).
Discussion
These findings suggest an important burden of both influenza
and RSV among persons with hospitalized SARI and outpatient
ILI in western Kenya, particularly among children aged ,5 years.
There is also likely an important burden of illness associated with
these viral pathogens in persons with SARI and ILI who do not
seek medical care.
The burden of severe respiratory disease associated with both
influenza and RSV was highest in children less than 23 months of
age, suggesting young children are an important potential target
group for current or future vaccines and other interventions in
Kenya. While pregnant women are a high risk group for influenza-
associated complications in their own right [25], our additional
finding that the burden of influenza associated SARI was highest
in those under six months of age further suggests the potential
value of vaccination of pregnant women as a way of protecting (via
maternal antibody transfer) those very young children for whom
no influenza vaccine is currently licensed [26]. These data
therefore support the 2012 recommendations by the WHO
Strategic Advisory Group of Experts on Immunization that
suggest pregnant women to be a high priority group for influenza
vaccination [27].
The rates of influenza-associated hospitalizations presented here
are comparable to the incidence reported in Kenya during the
period August 2010 to July 2011 [11]. These rates of hospitalized
influenza are also comparable to rates published for other
locations in Kenya [11], and to those reported in Bangladesh
and Thailand [28,29]. However these estimates of influenza-
associated hospitalizations in children ,5 years are nearly two
times higher than rates in the pre-pandemic period before 2009 in
the same region [13]. Importantly, they are also 3–7 times higher
than those reported recently in the United States [30,31].
Our adjusted incidence of hospitalizations associated with RSV
among children ,5 years [i.e. 5.2 (95% CI 4.0–6.8)] is nearly 2-
fold higher than the incidence reported in Kilifi, in the Coastal
part of Kenya [14], but is lower than rates published in a five-year
cohort study in South Africa. Even without adjustment, our
observed incidence rates of RSV in children under 24 months of
age also appear to be nearly twice those reported in the United
States [32]. We also observe that the incidence of RSV-associated
hospitalizations was higher than the incidence of influenza
hospitalizations in younger ages, but lower in older ages, which
is consistent with findings from other studies [31,33].
Our observed incidence of outpatient ILI-associated influenza
was only one-tenth of the rate reported in Bangladesh [28] but
over 2-fold higher than rates reported in England and Nether-
lands among children ,5 years [34]. As was the case with
influenza, our estimated incidence of ILI-associated RSV in
children ,5 years was over 5-times higher than the incidence
published in Europe [34].
Using adjustments for health seeking behaviors, our estimates
of the incidence of non-medically-attended SARI and ILI
associated with influenza and RSV were higher than compa-
rable rates of medically-attended illness in this community. This
highlights the need to consider burden of disease beyond the
health care facility to best inform public health policy in this
setting. Indeed, the 2005 survey indicated that only 48% of
children ,5 years and 34% of persons $5 years who reported
having pneumonia sought care at a hospital. Similarly, only
Figure 4. Rates of influenza and RSV associated SARI by distance from SDH, Aug 2009– Jul 2012.
doi:10.1371/journal.pone.0105543.g004
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42% of children ,5 years and 44% of persons $5 years who
reported having ARI in the two weeks preceding the health
utilization survey sought healthcare at any health facility [21].
These direct estimates therefore support international indirect
modeling efforts that have suggested influenza and RSV-
associated severe disease rates are substantially higher in Africa
and other lower resourced countries than elsewhere [2,3,5].
Our study was subject to several limitations. The SARI case
definition did not include wheezing, nasal flaring, tachypnea,
shortness of breath, and lethargy which have been associated
with RSV elsewhere, and may have resulted in an under
estimation of incidence of RSV, especially in very young
children [3,16,35]. This might explain why our RSV rates were
similar between infants aged ,6 months and 6–11 months,
which is inconsistent with other studies that report much higher
rates in younger infants [32]. However, the SARI case
definition that we used is broader than the new case definition
recommended by WHO which requires a history of fever or
measured fever [24]. There were an additional 30% SARI cases
identified using this case definition compared to what would
have been identified using the new WHO case definition. This
may have served to improve sensitivity and thus helped to
better estimate disease burden, in the very young children (,
6 months) and older persons who may be less likely to present
with fever as a component of influenza virus infections. The ILI
case definition – requiring a measured temperature of $38uC –
was used to estimate the burden of RSV among outpatients.
This also, as the case with SARI, may have possibly led to an
under estimation of the burden of RSV in outpatients, which
may be less likely than influenza to result in presentation with
fever [36,37]. The case definitions for ARI and pneumonia in
the 2005 health utilization survey were also both narrower in
scope than the ILI and SARI case definitions used in facility-
based surveillance, respectively. This could have led to an
underestimation of the incidence of illness in the community.
Another limitation was that we used adjustment factors from
a health utilization survey that was conducted in 2005–
four years earlier than the study period – to estimate the
burden of non-hospitalized and non-medically-attended illness.
Health seeking behaviors could have changed over that period
of time. Additionally, the survey was powered to estimate health
utilization among for both children ,5 years and persons $
5 years [21]. In this respect, the health utilization adjustments
may not have been as robust as ideal for the finer age-specific
rate adjustments that we undertook. For example, we applied
the same adjustment factor reported for health utilization
among under-fives for all age categories in children ,5 years
(,6 months, 6–11 months, 12–23 months, 2–4 years). If the
utilization rates differ across these age groups, then this could
bias our estimates. Conducting health utilizations surveys with
sufficient power in narrower age groups would serve to improve
future estimates.
There was also minimal testing for HIV especially among
younger persons and thus our study was not able to effectively
estimate incidence specifically in HIV positive and negative
populations. Lastly, we did not conduct a record review at
hospitals in the area other than SDH to determine the
proportion of residents of Karemo who went to other hospitals.
Instead, we assumed that every resident of Karemo who
required hospitalization would go to SDH. We felt this was a
reasonable approach given that the next nearest hospital was
located 17 KM away. To support this there were also no
observed differences between calculated incidence for persons
who lived within 5 KM, 10 KM, and 20 KM of SDH. The
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assumption behind this validation approach was that people
within very close proximity would seek care at SDH rather than
elsewhere and so we would have expected the incidence to
decline significantly with an increase in distance.
In conclusion, influenza and RSV both exact an important
disease burden in rural western Kenya, particularly in children ,
5 years old. These data suggest that a future RSV vaccine could
have important implications for child health in Kenya. The
immunization of children and pregnant women with currently
licensed influenza vaccines also has important potential to reduce
a significant cause of respiratory morbidity and mortality in
Kenya.
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